Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|December 30, 2020
The propriety of upgrading responses to venetoclax + azacitidine in newly diagnosed patients with acute myeloid leukemiaDiana Abbott, Evan Cherry, Maria Amaya, et al.
Bone Marrow Transplantation|May 15, 2023
Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapseAndrew Kent, Marc Schwartz, Christine McMahon, et al.
The Journal of Clinical Investigation|March 26, 2010
Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeysShahrooz S Kelishadi, Agnes M Azimzadeh, Tianshu Zhang, et al.
Science (New York, N.Y.)|February 9, 2013
(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversibleJulie-Aurore Losman, Ryan E Looper, Peppi Koivunen, et al.
Cancer Research|May 19, 2006
Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in miceTimothy S Fenske, Christine McMahon, Deepa Edwin, et al.
American Journal of Clinical Pathology|July 16, 2011
Spectrin isoforms: differential expression in normal hematopoiesis and alterations in neoplastic bone marrow disordersLucia R Wolgast, Linda A Cannizzarro, K H Ramesh, et al.
Blood|November 1, 2024
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AMLCurtis A Lachowiez, Vishvaas I Ravikumar, Jad Othman, et al.
Pageof 4